Duopharma which announced the extension of the Supply Agreements for the supply of pharmaceutical and/or non-pharmaceutical products by its wholly-owned subsidiary of Duopharma Biotech Berhad has informed that further extension has been given by its client, Pharmaniaga.
The group said it had received a letter from Pharmaniaga Logistics Sdn. Bhd. notifying that the Contract Period of the Supply Agreements for the supply of the products listed in the letter has been further extended until 31 December 2023 or such other date as may be directed by the Government, which could be earlier or later.
DMSB has notified its acceptance of the said extension it also said the Supply Agreements are in the ordinary course of business of the Company.
